Sprinter and marathoner CAR T cells reveal their distinct cancer-killing behavior
The study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.
Read More
CAR T cell
A potential new therapeutic target for Group 3 medulloblastoma
Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.
Read More
New insights into the mediators of patient recovery after CAR T cell immunotherapy
Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read More